The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market is being driven by Rise in awareness programs for HIV testing
The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market is expected to grow at a CAGR of 7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 338.3 million. The global health issue of Human Immunodeficiency Virus (HIV) necessitates continuous efforts towards prevention and control measures. Governments worldwide have implemented various initiatives, including pre-marital screening, to mitigate the risk of HIV transmission. Pre-marital screening involves health assessments of soon-to-be-married couples to identify the presence of infectious diseases, including HIV, and sexually transmitted diseases (STDs). This proactive measure prevents the further spread of diseases between couples and their offspring. The implementation of such programs has gained traction, particularly in developed countries like the US and emerging economies such as the UAE. The benefits of pre-marital screening are increasingly recognized, leading to a surge in the adoption of these testing programs.
Get more information on Human Immunodeficiency Virus (HIV) Rapid Test Kits Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
231 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7% |
Market growth 2025-2029 |
USD 338.3 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
6.0 |
Key countries |
US, Canada, China, UK, Japan, India, Germany, France, South Korea, and Italy |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market encompasses various testing options for the detection of HIV, including urine and oral fluid tests using p24 antigen and HIV-1/2 antibodies. Fifth and fourth generation tests are available, providing accurate results at the point-of-care. Service delivery through self-tests, treatment options, and testing for specific populations such as women, travelers, minorities, youth, men, seniors, LGBTQ+, immigrants, and refugees, are driving market growth. IVDs offer affordable and portable testing solutions, addressing stigma and discrimination associated with HIV testing in the context of global health. Antigen and antibody tests, blood tests, and home tests are key offerings in this market.
The global life sciences tools and services market encompasses businesses involved in the research and development (R&D) of a range of product categories, including HIV rapid test kits. These kits utilize advanced technologies such as immunofiltration and can detect HIV-1 and HIV-2 strains through urine samples or viral load testing. The market's expansion will be fueled by factors such as the growing need for self-testing and pre-exposure prophylaxis, as well as the increasing immune focus in disease diagnosis. Technavio's market analysis projects that the global healthcare market size will grow significantly due to the combined revenues generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. This growth can be attributed to the aging population, increasing prevalence of chronic diseases, and the ongoing development of innovative diagnostic tools and therapies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted